MARTIN STOGNIEW
Pharmacy in Blue Bell, PA
License number
Pennsylvania RP041499R
Category
Pharmacy
Type
Pharmacist
Address
Address
Blue Bell, PA 19422
Personal information
See more information about MARTIN STOGNIEW at radaris.comName
Address
Phone
Norristown, PA
1870 Ferguson Ln, Blue Bell, PA 19422
Organization information
See more information about MARTIN STOGNIEW at bizstanding.comMartin Stogniew, LLC
1870 Ferguson Ln, Blue Bell, PA 19422
Status:
Inactive
Industry:
Business Services at Non-Commercial Site
Principal:
Martin Stogniew Principal, inactive
Professional information
Pharmaceutical Formulations Comprising Aminoalkyl Phosphorothioates
US Patent:
6489312, Dec 3, 2002
Filed:
Jun 15, 1999
Appl. No.:
09/333411
Inventors:
Martin Stogniew - Blue Bell PA
Javad M. Zadei - West Chester PA
Javad M. Zadei - West Chester PA
Assignee:
MedImmune Oncology, Inc. - West Conshohocken PA
International Classification:
A61K 3166
US Classification:
514109, 514114
Abstract:
The present invention provides novel pharmaceutical compositions comprising aminoalkyl phosphorothioate compounds in combination with surfactants, hydrotropes and chelating agents. The compositions are well-suited for subcutaneous administration.
Methods Of Use Related To Xerostomia
US Patent:
2006004, Feb 23, 2006
Filed:
Oct 25, 2005
Appl. No.:
11/258335
Inventors:
Martin Stogniew - Blue Bell PA, US
David Alberts - Tucson AZ, US
Edward Kaplan - Skokie IL, US
David Alberts - Tucson AZ, US
Edward Kaplan - Skokie IL, US
International Classification:
A61K 31/13, A61K 31/66
US Classification:
514114000, 514665000
Abstract:
The present invention relates to new uses of thermally stable, crystalline S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by radiation treatment. In particular, the invention provides a method for treating or preventing xerostomia associated with the administration of radiation treatment of head and neck cancer.
Dalbavancin Compositions For Treatment Of Bacterial Infections
US Patent:
2009030, Dec 10, 2009
Filed:
May 29, 2009
Appl. No.:
12/474438
Inventors:
Luigi Colombo - Malnate, IT
Adriano Malabarba - Binasco, IT
Martin Stogniew - Blue Bell PA, US
Adriano Malabarba - Binasco, IT
Martin Stogniew - Blue Bell PA, US
International Classification:
A61K 38/16, A61P 31/04
US Classification:
514 8
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of a mixture of dalbavancin multimers and monomers for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Compositions comprise a mixture of dalbavancin multimer and monomer and a stabilizer, such as dextrose.
Topical Administration Of Amifostine And Related Compounds
US Patent:
6239119, May 29, 2001
Filed:
Apr 26, 1999
Appl. No.:
9/298824
Inventors:
Martin Stogniew - Blue Bell PA
Jean Bourhis - Sceaux, FR
Jean Bourhis - Sceaux, FR
Assignee:
MedImmune Oncology, Inc. - West Conshohocken PA
International Classification:
A61K 3166, A61K 3104
US Classification:
514131
Abstract:
The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.
Methods Of Administering Dalbavancin For Treatment Of Bacterial Infections
US Patent:
6900175, May 31, 2005
Filed:
Nov 14, 2003
Appl. No.:
10/714261
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard J. White - Emeryville CA, US
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard J. White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals Inc. - King of Prussia PA
International Classification:
A61K038/16
US Classification:
514 8
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
Antifungal Parenteral Products
US Patent:
6991800, Jan 31, 2006
Filed:
Jun 13, 2002
Appl. No.:
10/172678
Inventors:
Martin Stogniew - Blue Bell PA, US
Assignee:
Vicuron Pharmaceuticals Inc. - Fremont CA
International Classification:
A61K 9/08, A01N 25/04
US Classification:
424405, 424400, 514 23, 514359
Abstract:
Parenteral pharmaceutical formulations containing an echinocandin antifungal compound and an aqueous solvent are provided, wherein the formulation includes ethanol, for example about 20% w/v ethanol. The parenteral pharmaceutical formulation may further include one or more additives, such as a stabilizing agent, buffer or tonicity agent. The parenteral pharmaceutical formulations are useful in extending the shelf life and improving the solubility of the echinocandin antifungal compound.
Stable Compositions Of Dalbavancin
US Patent:
2004022, Nov 11, 2004
Filed:
Apr 20, 2004
Appl. No.:
10/829068
Inventors:
Marco Cavaleri - Saronno, IT
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
Daniela Jabes - Cassina Rizzardi, IT
Timothy Henkel - Berwyn PA, US
Adriano Malabarba - Buccinasco, IT
Giorgio Mosconi - Malvern PA, US
Martin Stogniew - Blue Bell PA, US
Richard White - Emeryville CA, US
Assignee:
Vicuron Pharmaceuticals, Inc. - King of Prussia PA
International Classification:
A61K031/704
US Classification:
514/037000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
Stabilized Compositions Of Alkylating Agents And Methods Of Using Same
US Patent:
8501818, Aug 6, 2013
Filed:
Jan 14, 2010
Appl. No.:
12/687605
Inventors:
Robert Alonso - Rye NH, US
Martin Stogniew - Blue Bell PA, US
Peter A. Crooks - Nicholasville KY, US
Mark A. Pimley - Westchester PA, US
David R. Worthen - Wakefield RI, US
Martin Stogniew - Blue Bell PA, US
Peter A. Crooks - Nicholasville KY, US
Mark A. Pimley - Westchester PA, US
David R. Worthen - Wakefield RI, US
Assignee:
Ceptaris Therapeutics, Inc. - Malvern PA
International Classification:
A01N 33/02, A61K 31/13
US Classification:
514672, 424400
Abstract:
Provided are stable compositions comprising alkylating agents, including nitrogen mustards, that are suitable for topical use, and methods for treating skin disorders comprising topically administering the compositions.
Dalbavancin Compositions For Treatment Of Bacterial Infections
US Patent:
2006007, Apr 6, 2006
Filed:
Apr 26, 2005
Appl. No.:
11/116064
Inventors:
Martin Stogniew - Blue Bell PA, US
Luigi Colombo - Malnate (VA), IT
Romeo Ciabatti - Novate Milanese, IT
Luigi Colombo - Malnate (VA), IT
Romeo Ciabatti - Novate Milanese, IT
Assignee:
VICURON PHARMACEUTICALS INC. - King of Prussia PA
International Classification:
A61K 38/16
US Classification:
514008000
Abstract:
The invention provides methods and compositions for treatment of bacterial infections. The composition may be a combination of factors, which include A, A, B, B, C, C, isoB, and MAG, in the presence of low level solvent. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimens include multiple dose administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection. Dosing regimens for renal patients are also included.
Methods For Treating Skin Disorders With Topical Nitrogen Mustard Compositions
US Patent:
2011003, Feb 17, 2011
Filed:
Sep 24, 2010
Appl. No.:
12/890183
Inventors:
Robert Alonso - Rye NH, US
Martin Stogniew - Blue Bell PA, US
Martin Stogniew - Blue Bell PA, US
International Classification:
A61K 31/131, A61P 17/00, A61P 31/10
US Classification:
514672
Abstract:
Provided are methods for treating skin disorders comprising topically applying to the affected skin a composition comprising a nitrogen mustard or a pharmaceutically acceptable salt thereof.